Diffuse targetoid and bullous skin lesions, mucositis, and ocular discharge in an adolescent male
Can you diagnose this adolescent with an 11-day history of diffuse targetoid and bullous lesions on his extremities and trunk?
Tackling clinical workforce challenges through innovation and effective leadership
As providers, it’s imperative to reward engagement and build on the successes of the professionals who invest their time and talent into the mission of our organization.
A preview of the September Tech issue of Contemporary Pediatrics
Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the August 2024 issue of Contemporary Pediatrics.
FDA approves neffy as first nasal spray to treat anaphylaxis
The approval is indicated for adult and pediatric patients who weight at least 66 pounds (30 kilograms).
Digital health programs and childhood obesity
Digital tools like health apps, texts, and telemedicine show promise in managing childhood obesity, but require sustained engagement for long-term impact.
Youth suicide decedents and documented preceding mental health diagnosis
Suicide was among the top 9 leading causes of death for people aged 10 to 64 years, and was the second leading cause of death for individuals aged 10 to 14 years and 25 to 34 years in 2022.
FDA alerting parents, caregivers of Cronobacter safety concerns in certain infant formula
The formula company issued a recall of the products on May 24, 2024, though they were not in compliance with all of the FDA’s infant formula regulations.
Dupilumab reduces exacerbations among children with severe asthma up to 2 years
These data highlighted new findings on the experiences of children aged 6 to 11 with uncontrolled type 2 asthma treated with dupilumab.
Probiotics: Beneficial to pediatric population during antibiotic treatment?
A secondary analysis of a randomized trial points to limited benefits on the microbiota.
